Tightly regulated trophoblast invasion and immunomodulation at the feto-maternal interface is important during implantation and fetal development. Although trophoblasts as a pregnancy-specific cell has been reported to be a key factor capable of regulating certain events during implantation, however, its regulatory mechanisms are still unclear. In this study, we analyzed the effects of chorionic plate-derived mesenchymal stem cells (CP-MSCs) and human placenta extract (hPE) isolated from human normal placentas on trophoblasts invasion and immune responses. We investigated the effects of CP-MSCs, hPE treatment, and their combination on trophoblasts invasion and on T-cells suppression through human leukocyte antigen-G (HLA-G) expression. Trophoblasts invasion was significantly increased by co-culture of CP-MSCs or by hPE treatment (P<0.05), and enhanced by the combination of CP-MSCs and hPE treatment (P<0.05). The proliferation of T-cells was decreased by co-culture of CP-MSCs and hPE treatment, whereas the population of regulatory T-cells was increased (P<0.05). Also, the dynamics alterations of multiple cytokines were observed in the culture supernatants of trophoblasts and T-cells depending on CP-MSCs co-culture and hPE treatment. Interestingly, the concentration of soluble HLA-G was increased by CP-MSCs co-culture, by hPE treatment and by combination of them on trophoblasts and activated T-cells (P<0.05). These findings suggested that CP-MSCs and hPE can regulate trophoblasts invasion and T-cell by alteration of HLA-G expression. These results will provide understandings of trophoblasts invasion and the immunological network at the feto-maternal interface during pregnancy and contribute to the foundation of a new treatment strategy for pregnancy disorders.
Yamamoto-TabataT, McDonaghS, ChangHT, FisherS and PereiraL. (2004). Human cytomegalovirus interleukin-10 downregulates metalloproteinase activity and impairs endothelial cell migration and placental cytotrophoblast invasiveness in vitro. J Virol, 78:2831–2840.
3.
Staun-RamE, GoldmanS, GabarinD and ShalevE. (2004). Expression and importance of matrix metalloproteinase 2 and 9 (MMP-2 and -9) in human trophoblast invasion. Reprod Biol Endocrinol, 2:59
4.
NaKH, LeeHJ, ChoiJH, EunJW, NamSW, YoonTK and KimGJ. (2012). Dynamic alterations in integrin alpha4 expression by hypoxia are involved in trophoblast invasion during early implantation. J Cell Biochem, 113:685–694.
5.
SamsteinRM, JosefowiczSZ, ArveyA, TreutingPM and RudenskyAY. (2012). Extrathymic generation of regulatory T cells in placental mammals mitigates maternal-fetal conflict. Cell, 150:29–38.
6.
SomersetDA, ZhengY, KilbyMD, SansomDM and DraysonMT. (2004). Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. Immunology, 112:38–43.
7.
Munoz-SuanoA, HamiltonAB and BetzAG. (2011). Gimme shelter: the immune system during pregnancy. Immunol Rev, 241:20–38.
8.
WingerEE and ReedJL. (2011). Low circulating CD4(+) CD25(+) Foxp3(+) T regulatory cell levels predict miscarriage risk in newly pregnant women with a history of failure. Am J Reprod Immunol, 66:320–328.
9.
SutmullerRP, MorganME, NeteaMG, GrauerO and AdemaGJ. (2006). Toll-like receptors on regulatory T cells: expanding immune regulation. Trends Immunol, 27:387–393.
10.
MiyaraM and SakaguchiS. (2007). Natural regulatory T cells: mechanisms of suppression. Trends Mol Med, 13:108–116.
11.
KopcowHD, AllanDS, ChenX, RybalovB, AndzelmMM, GeB and StromingerJL. (2005). Human decidual NK cells form immature activating synapses and are not cytotoxic. Proc Natl Acad Sci U S A, 102:15563–15568.
12.
McCormickJ, WhitleyGS, Le BouteillerP and CartwrightJE. (2009). Soluble HLA-G regulates motility and invasion of the trophoblast-derived cell line SGHPL-4. Hum Reprod, 24:1339–1345.
13.
ChauhanM, BalakrishnanM, YallampalliU, EndsleyJ, HankinsGD, TheilerR and YallampalliC. (2011). Adrenomedullin 2/intermedin regulates HLA-G in human trophoblasts. Biol Reprod, 85:1232–1239.
14.
HuntJS, PetroffMG, MoralesP, SedlmayrP, GeraghtyDE and OberC. (2000). HLA-G in reproduction: studies on the maternal-fetal interface. Hum Immunol, 61:1113–1117.
15.
SchwartzRE, ReyesM, KoodieL, JiangY, BlackstadM, LundT, LenvikT, JohnsonS, HuW and VerfaillieCM. (2002). Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest, 109:1291–1302.
16.
Sanchez-RamosJ, SongS, Cardozo-PelaezF, HazziC, StedefordT, WillingA, FreemanTB, SaportaS, JanssenW, et al. (2000). Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol, 164:247–256.
17.
NautaAJ and FibbeWE. (2007). Immunomodulatory properties of mesenchymal stromal cells. Blood, 110:3499–3506.
18.
HaoL, SunH, WangJ, WangT, WangM and ZouZ. (2012). Mesenchymal stromal cells for cell therapy: besides supporting hematopoiesis. Int J Hematol, 95:34–46.
19.
AbumareeM, Al JumahM, PaceRA and KalionisB. (2012). Immunosuppressive properties of mesenchymal stem cells. Stem Cell Rev, 8:375–392.
20.
NewmanRE, YooD, LeRouxMA and Danilkovitch-MiagkovaA. (2009). Treatment of inflammatory diseases with mesenchymal stem cells. Inflamm Allergy Drug Targets, 8:110–123.
21.
DuffyMM, RitterT, CeredigR and GriffinMD. (2011). Mesenchymal stem cell effects on T-cell effector pathways. Stem Cell Res Ther, 2:34
22.
LeeJM, JungJ, LeeHJ, JeongSJ, ChoKJ, HwangSG and KimGJ. (2012). Comparison of immunomodulatory effects of placenta mesenchymal stem cells with bone marrow and adipose mesenchymal stem cells. Int Immunopharmacol, 13:219–224.
23.
LeeHJ, ChaKE, HwangSG, KimJK and KimGJ. (2011). In vitro screening system for hepatotoxicity: comparison of bone-marrow-derived mesenchymal stem cells and placenta-derived stem cells. J Cell Biochem, 112:49–58.
24.
ShinKS, LeeHJ, JungJ, ChaDH and KimGJ. (2010). Culture and in vitro hepatogenic differentiation of placenta-derived stem cells, using placental extract as an alternative to serum. Cell Prolif, 43:435–444.
25.
KouttabNM, FowlerAK, StricklandJE and HellmanA. (1976). Suprresion of in vitro lymphocyte stimulation in mice by uterine and placental extracts. J Immunol, 117:1644–1650.
26.
ArkwrightPD, RademacherTW, BoutignonF, DwekRA and RedmanCW. (1994). Suppression of allogeneic reactivity in vitro by the syncytiotrophoblast membrane glycocalyx of the human term placenta is carbohydrate dependent. Glycobiology, 4:39–47.
27.
LeeMJ, JungJ, NaKH, MoonJS, LeeHJ, KimJH, KimGI, KwonSW, HwangSG and KimGJ. (2010). Anti-fibrotic effect of chorionic plate-derived mesenchymal stem cells isolated from human placenta in a rat model of CCl(4)-injured liver: potential application to the treatment of hepatic diseases. J Cell Biochem, 111:1453–1463.
28.
JungJ, LeeHJ, LeeJM, NaKH, HwangSG and KimGJ. (2011). Placenta extract promote liver regeneration in CCl4-injured liver rat model. Int Immunopharmacol, 11:976–984.
29.
YagiH, Soto-GutierrezA, ParekkadanB, KitagawaY, TompkinsRG, KobayashiN and YarmushML. (2010). Mesenchymal stem cells: mechanisms of immunomodulation and homing. Cell Transplant, 19:667–679.
30.
GnecchiM, ZhangZ, NiA and DzauVJ. (2008). Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res, 103:1204–1219.
31.
HorwitzEM and PratherWR. (2009). Cytokines as the major mechanism of mesenchymal stem cell clinical activity: expanding the spectrum of cell therapy. Isr Med Assoc J, 11:209–211.
32.
MohammadzadehM, HalabianR, GharehbaghianA, AmirizadehN, Jahanian-NajafabadiA, RoushandehAM and RoudkenarMH. (2012). Nrf-2 overexpression in mesenchymal stem cells reduces oxidative stress-induced apoptosis and cytotoxicity. Cell Stress Chaperones, 17:553–565.
33.
EirinA, ZhuXY, KrierJD, TangH, JordanKL, GrandeJP, LermanA, TextorSC and LermanLO. (2012). Adipose tissue-derived mesenchymal stem cells improve revascularization outcomes to restore renal function in swine atherosclerotic renal artery stenosis. Stem Cells, 30:1030–1041.
34.
SongC and LiG. (2011). CXCR4 and matrix metalloproteinase-2 are involved in mesenchymal stromal cell homing and engraftment to tumors. Cytotherapy, 13:549–561.
35.
OreshkovaT, DimitrovR and MourdjevaM. (2012). A cross-talk of decidual stromal cells, trophoblast, and immune cells: a prerequisite for the success of pregnancy. Am J Reprod Immunol, 68:366–373.
36.
FontanaVA, SanchezM, CebralE and CalvoJC. (2010). Interleukin-1 beta regulates metalloproteinase activity and leptin secretion in a cytotrophoblast model. Biocell, 34:37–43.
37.
BauerS, PollheimerJ, HartmannJ, HussleinP, AplinJD and KnoflerM. (2004). Tumor necrosis factor-alpha inhibits trophoblast migration through elevation of plasminogen activator inhibitor-1 in first-trimester villous explant cultures. J Clin Endocrinol Metab, 89:812–822.
38.
RamhorstR, FraccaroliL, AldoP, AlveroAB, CardenasI, LeirosCP and MorG. (2012). Modulation and recruitment of inducible regulatory T cells by first trimester trophoblast cells. Am J Reprod Immunol, 67:17–27.
39.
FraccaroliL, AlfieriJ, LaroccaL, CalafatM, MorG, LeirosCP and RamhorstR. (2009). A potential tolerogenic immune mechanism in a trophoblast cell line through the activation of chemokine-induced T cell death and regulatory T cell modulation. Hum Reprod, 24:166–175.
40.
ChenW, JinW, HardegenN, LeiKJ, LiL, MarinosN, McGradyG and WahlSM. (2003). Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med, 198:1875–1886.
41.
ZhengY, JosefowiczS, ChaudhryA, PengXP, ForbushK and RudenskyAY. (2010). Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature, 463:808–812.
42.
GobertM and LafailleJJ. (2012). Maternal-fetal immune tolerance, block by block. Cell, 150:7–9.
43.
KovatsS, MainEK, LibrachC, StubblebineM, FisherSJ and DeMarsR. (1990). A class I antigen, HLA-G, expressed in human trophoblasts. Science, 248:220–223.
44.
MenierC, RiteauB, DaussetJ, CarosellaED and Rouas-FreissN. (2000). HLA-G truncated isoforms can substitute for HLA-G1 in fetal survival. Hum Immunol, 61:1118–1125.
45.
RajagopalanS, BrycesonYT, KuppusamySP, GeraghtyDE, van der MeerA, JoostenI and LongEO. (2006). Activation of NK cells by an endocytosed receptor for soluble HLA-G. PLoS Biol, 4:e9
46.
ZavazavaN and KronkeM. (1996). Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes. Nat Med, 2:1005–1010.
47.
FonsP, ChabotS, CartwrightJE, LenfantF, L'FaqihiF, GiustinianiJ, HeraultJP, GueguenG, BonoF, et al. (2006). Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells. Blood, 108:2608–2615.
48.
LindamanA, DowdenA and ZavazavaN. (2006). Soluble HLA-G molecules induce apoptosis in natural killer cells. Am J Reprod Immunol, 56:68–76.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
